ライフサイエンスコーパス: collagen-induced arthritis

1 1.6 mg/kg and dose-dependent efficacy in rat collagen-induced arthritis.

2 on of arthritis in the experimental model of collagen-induced arthritis.

3 mechanical hyperalgesia and inflammation in collagen-induced arthritis.

4 h atRA suppressed progression of established collagen-induced arthritis.

5 odels of arthritis: Ab-induced arthritis and collagen-induced arthritis.

6 ining of joint tissue derived from mice with collagen-induced arthritis.

7 ts in a mouse model of autoimmune arthritis, collagen-induced arthritis.

8 llular and humoral immunity and the onset of collagen-induced arthritis.

9 re resistant to LPS-induced septic shock and collagen-induced arthritis.

10 and caspase-1(-/-) mice were susceptible to collagen-induced arthritis.

11 c T cells at the site of inflammation during collagen-induced arthritis.

12 ental autoimmune encephalomyelitis (EAE) and collagen-induced arthritis.

13 c (Tg) mice expressing HLA-DRB1*0401 develop collagen-induced arthritis.

14 ed animals in a systemic model of RA disease collagen-induced arthritis.

15 as attenuated disease in MRL/lpr mice and in collagen-induced arthritis.

16 Salmonella-CFA/I can protect DBA/1 mice from collagen-induced arthritis.

17 d its impact on the clinical model of bovine collagen-induced arthritis.

18 a T cells have also been found to exacerbate collagen-induced arthritis.

19 ptor family has a role in the progression of collagen-induced arthritis.

20 reduced the clinical and histologic signs of collagen-induced arthritis.

21 mmune mice, including T cells from mice with collagen-induced arthritis.

22 for B cells during the elicitation phase of collagen-induced arthritis.

23 use anti-mouse CD20 mAbs in a mouse model of collagen-induced arthritis.

24 ively correlated with paw swelling in murine collagen-induced arthritis.

25 optosis in thymocytes and pre-disposition to collagen-induced arthritis.

26 reduce the incidence and severity of murine collagen-induced arthritis.

27 efficacy in some animal models, most notably collagen-induced arthritis.

28 tic effect of sST2-Fc in the murine model of collagen-induced arthritis.

29 ansgenic mice that display susceptibility to collagen-induced arthritis.

30 of arthritis and in its ability to suppress collagen-induced arthritis.

31 therapeutic evaluation in a murine model of collagen-induced arthritis.

32 rotective, whereas loss of IL-12 exacerbates collagen-induced arthritis.

33 ice susceptible to porcine and human type II collagen-induced arthritis.

34 xperimental autoimmune encephalomyelitis and collagen-induced arthritis.

35 ad the capacity to prevent and/or ameliorate collagen-induced arthritis.

36 tage and IgG2a Ab's at the effector phase of collagen-induced arthritis.

37 pared following induction of monoclonal anti-collagen-induced arthritis.

38 of experimental models of arthritis, such as collagen-induced arthritis.

39 are normally susceptible to the induction of collagen-induced arthritis.

40 d particles inhibited development of type II collagen-induced arthritis.

41 combined anti-TNF-alpha/anti-CD4 therapy in collagen-induced arthritis.

42 nase 9 on the development and progression of collagen-induced arthritis.

43 o strongly alleviated disease development in collagen-induced arthritis.

44 exposure-dependent fashion in a rat model of collagen-induced arthritis.

45 immunocytokine F8-IL4 in the mouse model of collagen-induced arthritis.

46 ria significantly aggravated the severity of collagen-induced arthritis.

47 8-IL4 was able to cure mice with established collagen-induced arthritis.

48 hase that contributes to the pathogenesis of collagen-induced arthritis, a disease model of human rhe

49 act of TNF inhibition on IL-17 production in collagen-induced arthritis, a model of RA.

50 (EGFR), reduces the severity of established collagen-induced arthritis, a mouse model of RA, and tha

51 affords protection against joint disease in collagen-induced arthritis, a mouse model of rheumatoid

52 e the contribution of NK cells to regulating collagen-induced arthritis, a well-characterized preclin

53 60(p216) but not Qa-1-Qdm strongly inhibited collagen-induced arthritis, an animal model of human rhe

54 ed asthma-like allergic lung inflammation, a collagen-induced arthritis, an induced ulcerative coliti

55 close analog, SNX-4414, was evaluated in rat collagen-induced arthritis and adjuvant-induced arthriti

56 In collagen-induced arthritis and Ag-induced arthritis, alt

57 s of T15-NAb also efficiently inhibited both collagen-induced arthritis and anti-collagen II Ab-media

58 gen-specific CD4(+) T cell expansion in both collagen-induced arthritis and autoimmune diabetes mouse

59 BA/1 background were completely resistant to collagen-induced arthritis and exhibited absence of join

60 rity of the inflammatory autoimmune diseases collagen-induced arthritis and experimental autoimmune e

61 imal models of inflammatory diseases such as collagen-induced arthritis and experimental autoimmune e

62 the inflamed joint in arthritis in mice with collagen-induced arthritis and humans with RA.

63 in experimental allergic encephalomyelitis, collagen-induced arthritis and inflammatory bowel diseas

64 ved dendritic cells and in vivo in models of collagen-induced arthritis and inflammatory bowel diseas

65 miR-34a-deficient mice are resistant to collagen-induced arthritis and interaction of DCs and T

66 mit the incidence of arthritis in a model of collagen-induced arthritis and joint inflammation.

67 ese data indicate that ICOS is essential for collagen-induced arthritis and may suggest novel means f

68 d and activated in the synovium of mice with collagen-induced arthritis and patients with RA.

69 re increased in the lymph nodes of mice with collagen-induced arthritis and SLE.

70 ed up-regulation, mice developed more severe collagen-induced arthritis and spontaneous glomerular im

71 of disease severity and early onset in both collagen-induced arthritis and spontaneous lupus nephrit

72 IL-deficient mice are also hypersensitive to collagen-induced arthritis and streptozotocin-induced di

73 itis and its neutralization inhibited murine collagen-induced arthritis and suppressed IFN-gamma and

74 n that is up-regulated in the early stage of collagen-induced arthritis and that exacerbates arthriti

75 exhibited significantly reduced severity of collagen-induced arthritis and this was accompanied by a

76 7A in a mouse model of rheumatoid arthritis (collagen-induced arthritis) and the concomitant suscepti

77 PGRN-deficient mice were susceptible to collagen-induced arthritis, and administration of PGRN r

78 essed LPS-induced TNF production, alleviated collagen-induced arthritis, and blocked gout formation i

79 In contact hypersensitivity, collagen-induced arthritis, and inflammation induced by

80 odent models of polyarthritis: rat and mouse collagen-induced arthritis, and mouse collagen antibody-

81 sitivity model, suppress the onset on murine collagen-induced arthritis, and reduce the severity of e

82 mmune disease: systemic lupus erythematosus, collagen-induced arthritis, and serum-transfer arthritis

83 ted intravenously into mice with established collagen-induced arthritis, and the effects on leukocyte

84 essfully but had increased susceptibility to collagen-induced arthritis, and the levels of huTLR8 cor

85 osomes was able suppress the onset of murine collagen-induced arthritis as well as reduce severity of

86 iency of mPGES-1 inhibits the development of collagen-induced arthritis, at least in part, by blockin

87 their ability to prevent the development of collagen induced arthritis, both the engineered DR1-CII-

88 luorescence in arthritic joints of mice with collagen-induced arthritis by both noninvasive fluoresce

89 I vaccination of DBA/1 mice protects against collagen-induced arthritis by stimulating TGF-beta- and

90 of EC144 blocked disease development in rat collagen-induced arthritis by suppressing the inflammato

91 that IL-4 DCs exert a therapeutic effect on collagen-induced arthritis by targeting IL-17.

92 s study was to investigate the regulation of collagen-induced arthritis by tryptophan catabolism medi

93 iator for PGRN-mediated anti-inflammation in collagen-induced arthritis by using PGRN and IL-10 genet

94 models of autoimmune disease; in particular, collagen induced arthritis (CIA) and experimental autoim

95 Collagen induced arthritis (CIA) is an animal model of R

96 acious (ED(50) < or = 0.01 mg/kg) in the rat collagen induced arthritis (CIA) model.

97 efficacious (ED 50 = 0.05 mg/kg) in the rat collagen induced arthritis (CIA) model.

98 s marked changes in the preclinical phase of collagen induced arthritis (CIA).

99 y modified DC to suppress established murine collagen-induced arthritis (CIA) after i.v. delivery.

100 nd growth of bony spurs was performed in rat collagen-induced arthritis (CIA) and adjuvant-induced ar

101 level was dramatically elevated during mouse collagen-induced arthritis (CIA) and blocking TWEAK by a

102 complementary experimental RA mouse models, collagen-induced arthritis (CIA) and collagen antibody-i

103 letely halts and reverses the development of collagen-induced arthritis (CIA) and discover cellular a

104 SSRIs, fluoxetine and citalopram, in murine collagen-induced arthritis (CIA) and in a human ex vivo

105 n vivo mechanism of action was determined in collagen-induced arthritis (CIA) and local joint TLR5 li

106 Collagen-induced arthritis (CIA) and proteoglycan-induce

107 3 receptor alpha-chain, developed attenuated collagen-induced arthritis (CIA) and reduced ex vivo col

108 the development of pain in the rat model of collagen-induced arthritis (CIA) and to evaluate the con

109 her mucosal administration of EtxB can block collagen-induced arthritis (CIA) and to investigate the

110 perimental autoimmune encephalomyelitis, and collagen-induced arthritis (CIA) are associated with typ

111 actor Ag I (CFA/I) fimbriae protects against collagen-induced arthritis (CIA) by eliciting two regula

112 keyhole limpet hemocyanin (KLH) study and a collagen-induced arthritis (CIA) disease model of rheuma

113 s in RA, NK cells in the joints of mice with collagen-induced arthritis (CIA) express RANKL.

114 dy to test the hypothesis that resistance to collagen-induced arthritis (CIA) in C57BL/6 (B6) mice is

115 he objective of these studies was to examine collagen-induced arthritis (CIA) in C57BL/6 mice transge

116 stress protein, BiP, prevented induction of collagen-induced arthritis (CIA) in HLA-DRB*0101+/+ (HLA

117 Adjuvant-induced arthritis (AIA) and collagen-induced arthritis (CIA) in Lewis rats were used

118 he IL-15R on the prevention and treatment of collagen-induced arthritis (CIA) in mice and probed the

119 of a soluble ligand of CD200R in established collagen-induced arthritis (CIA) in mice and to analyze

120 We report herein that collagen-induced arthritis (CIA) in mice is inhibited by

121 A major difference between RA in humans and collagen-induced arthritis (CIA) in mice is the lack of

122 Collagen-induced arthritis (CIA) in mice is widely used

123 te the significance of these autoantibodies, collagen-induced arthritis (CIA) in mice was used to est

124 inhibitor BMS-345541 is efficacious against collagen-induced arthritis (CIA) in mice.

125 Collagen-induced arthritis (CIA) is a model of inflammat

126 The murine model of collagen-induced arthritis (CIA) is an established disea

127 MSCs transplantation (MSCT) into collagen-induced arthritis (CIA) mice prevented arthriti

128 ll depletion was further studied in a murine collagen-induced arthritis (CIA) model and a respiratory

129 The collagen-induced arthritis (CIA) model and DR-1 transgen

130 Oral efficacy in the murine collagen-induced arthritis (CIA) model for rheumatoid ar

131 s (PADs), are known to develop in the murine collagen-induced arthritis (CIA) model of inflammatory a

132 asts and pathological bone loss in the mouse collagen-induced arthritis (CIA) model of RA.

133 In a collagen-induced arthritis (CIA) model, neovascularizati

134 Immunization with collagen II, a collagen-induced arthritis (CIA) model, resulted in an a

135 In this study we show, using the DBA/1 collagen-induced arthritis (CIA) model, that conjugation

136 Using the collagen-induced arthritis (CIA) model, we have studied

137 In the collagen-induced arthritis (CIA) model, while ectopic ex

138 nti-arthritic effect of engineered MSCs in a collagen-induced arthritis (CIA) model.

139 the role of CRP in a mouse model of RA, the collagen-induced arthritis (CIA) model.

140 o evaluate MKK-3 and MKK-6 deficiency in the collagen-induced arthritis (CIA) model.

141 n vitro and to control disease severity in a collagen-induced arthritis (CIA) model.

142 itic joints of TSG-6 transgenic mice, in the collagen-induced arthritis (CIA) model.

143 ro, and joint inflammation and damage in the collagen-induced arthritis (CIA) model.

144 sing delayed-type hypersensitivity (DTH) and collagen-induced arthritis (CIA) models in mice.

145 The collagen-induced arthritis (CIA) mouse model is the most

146 r (uPA) reduces arthritis progression in the collagen-induced arthritis (CIA) mouse model to an exten

147 We used a collagen-induced arthritis (CIA) mouse model to study th

148 ) and the development of bone erosion in the collagen-induced arthritis (CIA) mouse.

149 of wild type (WT) versus CRIg(-/-) mice with collagen-induced arthritis (CIA) or K/BxN serum transfer

150 ynovial hyperplasia, and bone destruction in collagen-induced arthritis (CIA) rat models.

151 nvadosomal structures by synovial cells from collagen-induced arthritis (CIA) rats and RA patients.

152 Collagen-induced arthritis (CIA) represents an animal mo

153 Collagen-induced arthritis (CIA) represents an animal mo

154 of the MEK/ERK MAP kinase pathway in murine collagen-induced arthritis (CIA) using the selective MEK

155 Passive collagen-induced arthritis (CIA) was induced in Jnk2(-/-

156 Collagen-induced arthritis (CIA) was induced in male DBA

157 t and to identify their mechanism of action, collagen-induced arthritis (CIA) was therapeutically tre

158 This study in mice with established collagen-induced arthritis (CIA) was undertaken to deter

159 All pathological features of collagen-induced arthritis (CIA) were significantly redu

160 h carrageenan-induced acute inflammation and collagen-induced arthritis (CIA) were used to assess eff

161 the ability of these cells to control murine collagen-induced arthritis (CIA), a model for rheumatoid

162 e such product, ES-62, is protective against collagen-induced arthritis (CIA), a model of rheumatoid

163 Although the pathogenesis of collagen-induced arthritis (CIA), a model of rheumatoid

164 lator of inflammation was examined in murine collagen-induced arthritis (CIA), a model of rheumatoid

165 inflammation, contribute to the progress of collagen-induced arthritis (CIA), a mouse model for RA.

166 toring and quantifying joint inflammation in collagen-induced arthritis (CIA), a mouse model for RA.

167 ene knockout (KO) mice to assess its role in collagen-induced arthritis (CIA), a mouse model of human

168 arthritis shows any similarities with RA or collagen-induced arthritis (CIA), a mouse model of RA.

169 mmunoregulatory protein for the treatment of collagen-induced arthritis (CIA), a mouse model of rheum

170 ets, Vgamma1(+) and Vgamma4(+) cells, during collagen-induced arthritis (CIA), a mouse model that sha

171 eptibility of CD73-deficient C57BL/6 mice to collagen-induced arthritis (CIA), a well-established mou

172 table for use in DBA/1LacJ mice that develop collagen-induced arthritis (CIA), an animal model of hum

173 and evaluated their therapeutic potential in collagen-induced arthritis (CIA), an animal model of RA.

174 elayed the onset and reduced the severity of collagen-induced arthritis (CIA), and reduced paw tissue

175 immune responses, led to early resolution of collagen-induced arthritis (CIA), and reduced spontaneou

176 In collagen-induced arthritis (CIA), preventive and therape

177 Upon induction of collagen-induced arthritis (CIA), tau-tg mice displayed

178 In mice with collagen-induced arthritis (CIA), the disease-modulating

179 We assessed pain behavior and mechanisms in collagen-induced arthritis (CIA), the model of preclinic

180 When transferred into mice with collagen-induced arthritis (CIA), this T cell line speci

181 cient in IL-1Ra (IL-1Ra(-/-)) were bred with collagen-induced arthritis (CIA)-susceptible DBA/1 mice

182 ed in human rheumatoid arthritis (RA) and in collagen-induced arthritis (CIA).

183 a therapeutic agent was evaluated in murine collagen-induced arthritis (CIA).

184 cally delivered into the ankles of mice with collagen-induced arthritis (CIA).

185 matory joint disease in mice challenged with collagen-induced arthritis (CIA).

186 was down-modulated during the progression of collagen-induced arthritis (CIA).

187 in the chronic inflammatory arthritis model collagen-induced arthritis (CIA).

188 is adaptor is required for the initiation of collagen-induced arthritis (CIA).

189 g an anti-mouse CD70 Ab in a murine model of collagen-induced arthritis (CIA).

190 Administration of misoprostol exacerbated collagen-induced arthritis (CIA).

191 motif (FibgammaDelta5), were challenged with collagen-induced arthritis (CIA).

192 imatinib potently prevents and treats murine collagen-induced arthritis (CIA).

193 emonstrated that p53 is protective in murine collagen-induced arthritis (CIA).

194 J mice to study the role of CD44 directly in collagen-induced arthritis (CIA).

195 8.CD4(-/-) mice were resistant to developing collagen-induced arthritis (CIA).

196 in a model of rheumatoid arthritis, namely, collagen-induced arthritis (CIA).

197 with bovine type II collagen (CII) to elicit collagen-induced arthritis (CIA).

198 uated in cultured Jurkat cells and in murine collagen-induced arthritis (CIA).

199 ion, including rheumatoid arthritis (RA) and collagen-induced arthritis (CIA).

200 anti-inflammatory proteins that can suppress collagen-induced arthritis (CIA).

201 used to locate CRIg expression in mice with collagen-induced arthritis (CIA).

202 testing in an in vivo model of inflammation, collagen-induced arthritis (CIA).

203 destructive arthritis in the murine model of collagen-induced arthritis (CIA).

204 collagen and yet have a reduced incidence of collagen-induced arthritis (CIA).

205 using a mouse model of autoimmune arthritis, collagen-induced arthritis (CIA).

206 ed natural Treg (nTreg) cells on established collagen-induced arthritis (CIA).

207 response gene with CII elicits an arthritis (collagen-induced arthritis [CIA]) that resembles rheumat

208 nificantly reduced incidence and severity of collagen-induced arthritis compared with wild-type (WT)

209 In collagen-induced arthritis, deficiency of endogenous Anx

210 more effective than monotherapy in improving collagen-induced arthritis disease even when administere

211 In addition, 31 demonstrated efficacy in a collagen-induced arthritis disease model in rats.

212 nic mice developed more severe and sustained collagen-induced arthritis due to the enhanced Th1 respo

213 We demonstrated that murine collagen-induced arthritis follows a similar sequential

214 3, ASC, and caspase-1 in the pathogenesis of collagen-induced arthritis have not been characterized.

215 arthritis, IFN-gamma is required, whereas in collagen-induced arthritis, IL-17 is necessary for devel

216 , HNK stabilized the severity of symptomatic collagen-induced arthritis in both CD40-LMP1 transgenic

217 elayed the onset and reduced the severity of collagen-induced arthritis in DBA/1 mice by induction of

218 n DBA/1-TCR-beta transgenic mice, as well as collagen-induced arthritis in DBA/1 mice, both animal mo

219 vivo in an autoimmune disease model, namely, collagen-induced arthritis in DBA/1 mice.

220 e autoimmune inflammatory process of chronic collagen-induced arthritis in DBA/1-TCR-beta transgenic

221 We showed that this peptide ameliorates collagen-induced arthritis in DBA/1J mice and protects a

222 i-inflammation could be unveiled by studying collagen-induced arthritis in Gal-1(-/-) mice.

223 protein LTbetaR-Ig blocked the induction of collagen-induced arthritis in mice and adjuvant arthriti

224 nistration of ERG240 reduces the severity of collagen-induced arthritis in mice and crescentic glomer

225 eptide significantly reduced the severity of collagen-induced arthritis in mice by reducing levels of

226 25 in vivo down-regulates the progression of collagen-induced arthritis in mice via targeting of the

227 8 kinase activities and clinical symptoms of collagen-induced arthritis in mice were all diminished.

228 In addition to EAE, p40 also suppressed collagen-induced arthritis in mice.

229 itis in the models of adjuvant arthritis and collagen-induced arthritis in rats and mice, respectivel

230 Susceptibility to experimental collagen-induced arthritis in rodents is dependent on MH

231 on of DRB1*0402 did not lead to induction of collagen-induced arthritis in transgenic mice.

232 We studied serotonin's involvement during collagen-induced arthritis in wild-type and Tph1(-/-) mi

233 ne models of chronic inflammation, including collagen-induced arthritis, inflammatory bowel disease,

234 Collagen-induced arthritis is a commonly accepted model

235 Chronic relapsing homologous collagen-induced arthritis is a valuable model for ident

236 Collagen-induced arthritis is a well-validated, but stra

237 4) enhanced Th17 expansion, and in mice with collagen-induced arthritis it facilitated disease onset,

238 ecule on T lymphocytes, CD40(+) T cells from collagen-induced arthritis mice were examined in paralle

239 so potent in treating established disease in collagen-induced arthritis mice with beneficial effects

240 eutic action of tolerogenic DCs in a type II collagen-induced arthritis model and to investigate thei

241 rat and dog and was found to be active in a collagen-induced arthritis model in rats.

242 ing of GLPG0634 in a therapeutic set-up in a collagen-induced arthritis model in rodents resulted in

243 n vivo, because inhibition of C5orf30 in the collagen-induced arthritis model markedly accentuated jo

244 odel of systemic lupus erythematosus and the collagen-induced arthritis model of rheumatoid arthritis

245 We used the murine collagen-induced arthritis model to characterize the imm

246 cells to the inflammatory site, we used the collagen-induced arthritis model to determine the freque

247 mice, but not DBA/1J (the strain used in the collagen-induced arthritis model) or DBA/2J mice.

248 fficacy in adjuvant-induced arthritis model, collagen-induced arthritis model, and allergic asthma mo

249 In a mouse collagen-induced arthritis model, EC144 also suppressed

250 In a prophylactic collagen-induced arthritis model, it exhibited an anti-i

251 In a murine collagen-induced arthritis model, JNJ-54271074 dose-depe

252 xin-1 increased skewing in Th1 cells; in the collagen-induced arthritis model, treatment of mice with

253 In the type II collagen-induced arthritis model, we observed a signific

254 (1-propionylpiperidin-4-yl) urea (TPPU) on a collagen-induced arthritis model.

255 ion and cartilage destruction in this murine collagen-induced arthritis model.

256 m 50 to 80% and is milder than the classical collagen-induced arthritis model.

257 /PD assays and highly efficacious in a mouse collagen-induced arthritis model.

258 role of ICOS in rheumatoid arthritis using a collagen-induced arthritis model.

259 Efficacy of GLPG0634 in the collagen-induced arthritis models was comparable to the

260 Here, we examine the therapeutic effects in collagen-induced arthritis of the second generation PAD

261 In a model of collagen-induced arthritis on the C57BL/6 background, th

262 e, IL-35 inhibited clinical manifestation of collagen-induced arthritis or could cease further diseas

263 ntigens emulsified in adjuvant oils, such as collagen-induced arthritis or experimental autoimmune en

264 In mice with collagen-induced arthritis, orally administered PCI-3276

265 Remarkably, the collagen-induced arthritis phenotype of Ccr2-/- mice mim

266 kine analysis shows that mice protected from collagen-induced arthritis produce lower amounts of Th1

267 n up to 1 month before the clinical onset of collagen-induced arthritis protected mice from severe jo

268 -AIA in DA.F344 monocongenic rats containing collagen-induced arthritis QTLs.

269 Treatment of mice with established collagen-induced arthritis reduced the severity of arthr

270 s biomarkers in RA, enhance tissue damage in collagen-induced arthritis (see the related article begi

271 Crucially, ES-62 was also found to suppress collagen-induced arthritis severity and progression when

272 tained anti-inflammatory activity in vivo in collagen induced arthritis studies in mouse but had redu

273 Collagen induced arthritis studies in mouse have demonst

274 In paws taken from the collagen-induced arthritis study, the bones of vehicle-t

275 DBA/2J) to investigate the genetic basis of collagen-induced arthritis susceptibility.

276 This motif is similar to one recognized by collagen-induced arthritis-susceptible HLA-DR1- and HLA-

277 Using a novel collagen-induced arthritis synovial window model, we dem

278 hat Fas-deficient mice developed less-severe collagen-induced arthritis than did control mice.

279 hma-like allergic lung inflammation and of a collagen-induced arthritis, the CpdX antiinflammatory ac

280 When administered in vivo to mice with collagen-induced arthritis, the SE ligand significantly

281 es are a prerequisite for the development of collagen-induced arthritis, their presence is insufficie

282 ivo studies were conducted in a rat model of collagen-induced arthritis to evaluate the therapeutic p

283 The effect of IDO deficiency on collagen-induced arthritis was assessed in vivo by admin

284 signal, a TCR-transgenic (Tg) mouse model of collagen-induced arthritis was developed.

285 ed disease, the efficacy of rh-FcgammaRIA in collagen-induced arthritis was evaluated.

286 Collagen-induced arthritis was induced in mice hypomorph

287 In addition, we report that collagen-induced arthritis was not affected by the funct

288 While analyzing gene expression in collagen-induced arthritis, we discovered that a poorly

289 termine the role CD28 costimulation plays in collagen-induced arthritis, we have generated DQ8 transg

290 In a model of collagen-induced arthritis, we use S100A8/S100A9 imaging

291 ation, late phase cutaneous anaphylaxis, and collagen-induced arthritis were aggravated, in contrast

292 T cell activation and its ability to prevent collagen-induced arthritis were analyzed.

293 Penetrance, onset, and severity of collagen-induced arthritis were recorded in DUSP-1+/+ an

294 The incidence and severity of collagen-induced arthritis were significantly reduced an

295 Male DBA/1J mice with collagen-induced arthritis were treated with etanercept.

296 models of delayed-type hypersensitivity and collagen-induced arthritis were used.

297 er inflammation of the knee joints following collagen-induced arthritis, when compared with control m

298 *0401 gene contributes to the development of collagen-induced arthritis, whereas DRB1*0402 prevents t

299 ays a dominant role in the susceptibility to collagen-induced arthritis, whereas FcgammaRIIb on B cel

300 ent development of inflammation in mice with collagen-induced arthritis, whereas sorted CD25+CD39+CD4

301 DQ8.CD28(-/-) mice develop collagen-induced arthritis with delayed onset and less s